Biotech News
Related news
HYPRHyperfine2026-09-15 12:15 EST
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
HYPRHyperfine2026-08-20 12:15 EST
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
VTAKCatheter Precision2026-09-17 12:00 EST
Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil
CVRXCVRx2026-08-25 12:00 EST
CVRx Responds to Letter from Pointillist Family Office
NEPHNephros2026-07-06 11:00 EST
Nephros Announces Inclusion in the Russell Microcap® Index
CVRXCVRx2026-08-24 12:30 EST
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
VTAKCatheter Precision2026-08-27 12:00 EST
Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
PAVMPAVmed2026-08-05 12:46 EST
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
PAVMPAVmed2026-08-04 12:30 EST
Lucid Diagnostics to Participate in Upcoming Investor Conferences
ICCMIceCure Medical2026-07-14 12:32 EST
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
Hyperfine
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...
Recent company news
HYPRHyperfine2026-09-15 12:15 EST
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
HYPRHyperfine2026-08-31 12:15 EST
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
HYPRHyperfine2026-08-26 12:15 EST
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
HYPRHyperfine2026-08-20 12:15 EST
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
HYPRHyperfine2026-08-06 20:05 EST
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
Stock data
- Close
- 0.77 USD
- Market cap
- 148.91M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States